Skip to content

Insider · CIK 0001436075

Christopher D. Maggiore

directorowner

Files at ZIVO (Zivo Bioscience, Inc.). First filing Apr 9, 2025, latest Jan 27, 2026.

In brief

Christopher D. Maggiore files SEC Form 4 as director and 10% owner at ZIVO (Zivo Bioscience, Inc.). Since Apr 9, 2025, Christopher D. Maggiore has reported 2 open-market buys worth $299k and 1 open-market sell worth $325, the latest filed on Jan 27, 2026.

A track record needs three past buys with six months of prices behind them; Christopher D. Maggiore has 0, so none is measured yet.

The newest scored trade: bought $15k of ZIVO on Jan 14, 2026, filed Jan 27, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $15k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$299k bought, $325 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ZIVO: Zivo Bioscience, Inc.

ZIVOOct 9, 2026 · close 5.30

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
ZIVObuy 4
Zivo Bioscience, Inc.
$15k
1,766 shares
+0%+29% from low-58% from high
52Moderate
ZIVObuy 3
Zivo Bioscience, Inc.
$284k
23,682 shares
+5%+20% from low-46% from high
15Weak
ZIVOsell
Zivo Bioscience, Inc.
$325
20 shares
-0%+43% from low-23% from high

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 14, 2026ZIVO
Zivo Bioscience, Inc.
POpen-market purchase
Common Stock
+1,766$8.49$15k519,292Jan 27, 2026
Oct 8, 2025ZIVO
Zivo Bioscience, Inc.
POpen-market purchase
Common Stock
+23,682$12.01$284k517,526Oct 9, 2025
Oct 2, 2025ZIVO
Zivo Bioscience, Inc.
AGrant or award
Nonstatutory Stock Options to buy Common Stockderivative
+1,075$10.20$11k1,075Oct 6, 2025
Apr 8, 2025ZIVO
Zivo Bioscience, Inc.
SOpen-market sale
Common Stock
-20$16.25$325507,000Apr 9, 2025

Questions about Christopher D. Maggiore

Answered from the filings on this page, as of the latest one.

Is Christopher D. Maggiore buying or selling?

In the last 12 months Christopher D. Maggiore reported 1 open-market buy worth $15k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $15k of ZIVO on Jan 14, 2026. Grants, option exercises and tax withholding are not counted.

How did Christopher D. Maggiore's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher D. Maggiore has 0.

Where does Christopher D. Maggiore file Form 4?

Christopher D. Maggiore has filed Form 4 at ZIVO (Zivo Bioscience, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher D. Maggiore: insider trades and track record | InsiderTell